Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1

Conditions

Skin Neoplasms 3Sarcoma, Kaposi 2Melanoma 2HIV Infections 2Squamous Cell Carcinoma of Head and Neck 1Neoplasms, Unknown Primary 1Nasopharyngeal Neoplasms 1Head and Neck Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

veliparib 1tislelizumab 1spartalizumab 1erythromycin propionate-N-acetylcysteinate 1entinostat 1atezolizumab 1Transurethral Resection of Prostate 1Taxes 1Surveys and Questionnaires 1Semaxinib 1Radiosurgery 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Irinotecan 1Immunotherapy 1Immunohistochemistry 1Genetic Profile 1Gemcitabine 1Fluorodeoxyglucose F18 1Filgrastim 1FAPI-46 1Drug Therapy 1Docetaxel 1Cyclophosphamide 1Cryosurgery 1Carboplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Unknown Primary × Semaxinib × Dermatologic × Clear all
NCT00006361 2009-12-04

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

National Cancer Institute (NCI)

Phase 2 Completed
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡